~~<i id='3E237EBC4B'><strike id='3E237EBC4B'><tt id='3E237EBC4B'><pre id='3E237EBC4B'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：entertainment 2025-10-02 13:04:13 - browse：459

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： BD to buy Edwards patient monitoring unit for $4.2 billion

knowledge

entertainment

focus

knowledge

Wikipedia

MikeReddyforSTATIwasrecentlyworkingwithayoungmotherwhostruggledwithdepressionandanxietyinthedifficul

WSS

For pregnant people, addiction treatment shouldn't mean a call to child protective services

STAT wants to know your pick for a great summer read or listen

Gene editing the human germline: What are the risks?

Stop the failed accountable care organization experiment

Medicare Advantage's lean provider networks lead CMS complaints

Congress needs to close a vaccine

entertainment

entertainment

knowledge

Bright Health sells Medicare Advantage business to Molina

Elevance PBM president out as customers face prescription chaos

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Physicians and social media: If you see something, say something?

At least 13 dead in Texas as scorching temps continue

Colonoscopy prep: Liquid

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Affirmative action in medical school literally saved lives

ASCO Takeaways: Winners, snoozers, and the art of cancer care

entertainment

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Asbestos, a deadly carcinogen, banned by EPA

STAT wants to know your pick for a great summer read or listen

Senators tussle over abortion against the backdrop of a presidential campaign

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

'Little Tech' descents on D.C., wanting a say in how AI is regulated

focus

knowledge

knowledge

Wikipedia